Sign in to view content

Prophylactic Ranibizumab for Exudative AMD in Vulnerable Eyes With Nonexudative AMD Trial (PREVENT) A Prospective Controlled Clinical Trial

Maziar Lalezary, MD, FASRS

Video
Published 2018

Related

Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2018
Visual Outcomes of Primary Versus Secondary Epiretinal Membrane Following Vitrectomy and Cataract Surgery
Mohmed K Soliman, MD, MSc
Annual Meeting Talks
2018
My Practice is Worth WHAT? Equity Acquisition in the Retina World
Robert L. Avery, MD
Carl W. Baker, MD, FASRS
Michael S. Jacobson, MD
Reginald J. Sanders, MD, FASRS
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more